Legal & General Group PLC Ptc Therapeutics, Inc. Transaction History

Legal & General Group PLC

  • $470 Billion
  • Q3 2024

A detailed history of Legal & General Group PLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 85,575 shares of PTCT stock, worth $4.02 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
85,575
Previous 85,575 -0.0%
Holding current value
$4.02 Million
Previous $3.17 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$30.39 - $37.66 $74,121 - $91,852
2,439 Added 2.93%
85,575 $3.17 Million
Q2 2024

Aug 14, 2024
BUY
$24.69 - $40.12 $277,466 - $450,868
11,238 Added 15.63%
83,136 $2.54 Million
Q1 2024

May 14, 2024
SELL
$24.15 - $31.95 $397,243 - $525,545
-16,449 Reduced 18.62%
71,898 $2.09 Million
Q4 2023

Feb 15, 2024
SELL
$18.07 - $29.37 $222,676 - $361,926
-12,323 Reduced 12.24%
88,347 $2.43 Million
Q3 2023

Nov 14, 2023
BUY
$22.41 - $41.99 $47,666 - $89,312
2,127 Added 2.16%
100,670 $2.26 Million
Q2 2023

Aug 14, 2023
SELL
$40.4 - $59.1 $437,855 - $640,525
-10,838 Reduced 9.91%
98,543 $4.01 Million
Q1 2023

May 15, 2023
BUY
$38.16 - $48.86 $898,286 - $1.15 Million
23,540 Added 27.42%
109,381 $5.3 Million
Q4 2022

Feb 14, 2023
BUY
$33.53 - $54.79 $176,468 - $288,359
5,263 Added 6.53%
85,841 $3.28 Million
Q3 2022

Nov 14, 2022
SELL
$41.85 - $53.85 $417,328 - $536,992
-9,972 Reduced 11.01%
80,578 $4.05 Million
Q2 2022

Aug 22, 2022
SELL
$25.6 - $45.23 $19,481 - $34,420
-761 Reduced 0.83%
90,550 $3.63 Million
Q1 2022

May 16, 2022
BUY
$33.33 - $44.6 $210,312 - $281,426
6,310 Added 7.42%
91,311 $3.41 Million
Q4 2021

Feb 14, 2022
SELL
$35.36 - $41.86 $18,139 - $21,474
-513 Reduced 0.6%
85,001 $3.39 Million
Q3 2021

Nov 15, 2021
BUY
$37.01 - $44.74 $1.49 Million - $1.8 Million
40,344 Added 89.32%
85,514 $3.18 Million
Q2 2021

Aug 12, 2021
BUY
$37.95 - $49.37 $280,108 - $364,399
7,381 Added 19.53%
45,170 $1.91 Million
Q1 2021

May 17, 2021
SELL
$46.8 - $68.92 $118,310 - $174,229
-2,528 Reduced 6.27%
37,789 $1.79 Million
Q4 2020

Feb 12, 2021
BUY
$47.96 - $67.64 $295,913 - $417,338
6,170 Added 18.07%
40,317 $2.46 Million
Q3 2020

Nov 13, 2020
SELL
$45.41 - $57.07 $647,092 - $813,247
-14,250 Reduced 29.44%
34,147 $1.6 Million
Q2 2020

Aug 14, 2020
BUY
$42.56 - $54.98 $289,535 - $374,028
6,803 Added 16.36%
48,397 $2.46 Million
Q1 2020

May 14, 2020
BUY
$32.37 - $59.36 $62,797 - $115,158
1,940 Added 4.89%
41,594 $1.87 Million
Q4 2019

Feb 13, 2020
BUY
$32.22 - $50.07 $145,183 - $225,615
4,506 Added 12.82%
39,654 $1.9 Million
Q3 2019

Nov 13, 2019
BUY
$33.82 - $48.17 $6,797 - $9,682
201 Added 0.58%
35,148 $1.19 Million
Q2 2019

Aug 14, 2019
SELL
$35.42 - $45.0 $1.06 Million - $1.35 Million
-29,916 Reduced 46.12%
34,947 $1.57 Million
Q1 2019

May 15, 2019
BUY
$28.09 - $39.49 $1.43 Million - $2.02 Million
51,059 Added 369.89%
64,863 $2.44 Million
Q4 2018

Feb 15, 2019
BUY
$29.83 - $46.51 $62,016 - $96,694
2,079 Added 17.73%
13,804 $473,000
Q3 2018

Nov 20, 2018
BUY
$33.9 - $47.77 $27,730 - $39,075
818 Added 7.5%
11,725 $550,000
Q2 2018

Aug 10, 2018
SELL
$25.7 - $47.88 $13,543 - $25,232
-527 Reduced 4.61%
10,907 $368,000
Q1 2018

May 17, 2018
BUY
$17.46 - $32.59 $25,858 - $48,265
1,481 Added 14.88%
11,434 $309,000
Q4 2017

Feb 13, 2018
BUY
$15.14 - $20.89 $150,688 - $207,918
9,953
9,953 $166,000

Others Institutions Holding PTCT

# of Institutions
222
Shares Held
78.1M
Call Options Held
144K
Put Options Held
58.7K
View Full List

About PTC THERAPEUTICS, INC.

PTCT Quotes by TradingView
  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.36B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email